Recalling P446. P4501A1 (CYP1A1) Opting for Clinical Application

REFERENCES

• Alvares A. P., Schilling G., Levin W., Kuntzman R. Studies on the induction of CO-binding pigments in liver microsomes by phenobarbital and 3-methylcholanthrene. Biochem. Biophys. Res. Commun. 1967; 29: 521–526
   PubMed Web of Science ®Google Scholar
• Bale A. E., Nebert D. W., McBride O. W. Subchromosomal localization of the dioxin-inducible P1-450 locus (CYP1) and description of two RFLPs detected with a 3'P1-450 cDNA probe. Cytogenet. Cell Genet. 1987; 46: 574–575
   Google Scholar
• Burke M. D., Prough R. A., Richard T. Characteristics of a microsomal cytochrome P448 mediated reaction. Drug Metabol. Dispos. 1977; 5: 1–8
   PubMed Web of Science ®Google Scholar
• Cammer W., Schenkman J. B., Estabrook R. W. EPR measurements of substrate interaction of cytochrome P-450. Biochem. Biophys. Res. Commun. 1966; 23: 264–268
   PubMed Web of Science ®Google Scholar
• Cascorbi I., Brockmöller J., Roots I. A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996; 56: 4965–4969
   PubMed Web of Science ®Google Scholar
• Chernogolov A., Behlke J., Schunck W.-H., Roots I., Schwarz D. Human CYP1A1 allelic variants: baculovirus expression and purification, hydrodynamic, spectral, and catalytical properties and their potency in the formation of all-trans-retinoic acid. Protein Expr. Purif. 2003; 28: 259–269
   PubMed Web of Science ®Google Scholar
• Conney A. H. Induction of drug metabolizing enzymes: A path to the discovery of multiple cytochromes P450. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 1–30
   PubMed Web of Science ®Google Scholar
• Conney A. H., Lu Y., Lou Y., Xie J., Huang M. Inhibitory effect of green and black tea on tumor growth. Proc. Soc. Exp. Biol. Med. 1999; 220: 229–233
   PubMed Web of Science ®Google Scholar
• Crofts F., Taioli E., Trachman J., Cosma G. N., Curie D., Toniolo P., Garte S. J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 15: 2961–2963
   PubMed Web of Science ®Google Scholar
• Drakoulis N., Cascorbi I., Brockmöller J., Gross C. R., Roots I. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clin. Investig. 1994; 72: 240–248
   PubMedGoogle Scholar
• Estabrook R. W. Discovering the functions of cytochrome P450 in drug metabolism: The role of Alfred Hildebrandt. Drug Metab. Rev. 1999; 31: 317–331
   PubMed Web of Science ®Google Scholar
• Estabrook R. W. A passion for P450s (Remembrances of the early history of research on cytochrome P450). Drug Metab. Disposit. 2003; 31: 1461–1473
   PubMed Web of Science ®Google Scholar
• Estabrook R. W., Cooper D.Y., Rosenthal O. The light-reversible carbon monoxide inhibition of the steroid C-21 hydroxylation system of the adrenal cortex. Biochem. Z. 1963; 338: 741–755
   PubMedGoogle Scholar
• Estabrook R. W., Peterson J. A., Baron J., Hildebrandt A. G. The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism. Methods in Pharmacology, C. F. Chignell. Appleton-Century-Crofts, New York 1972; 2: 303–350
   Google Scholar
• Guengerich F. P. Cytochrome P450: What have we learned and what are the future issues?. Drug Metab. Rev. 2004; 36: 159–197
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest. J. Biol. Chem. 1977; 252: 3970–3979
   PubMed Web of Science ®Google Scholar
• Hashimoto Y., Yamano T., Mason H. S. An electron spin resonance study of microsomal electron transport. J. Biol. Chem. 1962; 237: 3843–3844
   PubMed Web of Science ®Google Scholar
• Haugen D. A., Coon M. J. Properties of electrophoretically homogeneous phenobarbital-inducible and β-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem. 1976; 251: 7929–7939
   PubMed Web of Science ®Google Scholar
• Hayashi S., Watanabe J., Nakachi K., Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem. 1991; 110: 407–411, (Tokyo).
   PubMed Web of Science ®Google Scholar
• Hildebrandt A. Die beschleunigte Elimination von Sulfadimethoxin bei Hunden durch Phenobarbital. MD Thesis. Medical Faculty. University Tübingen, Germany 1965
   Google Scholar
• Hildebrandt A. G., Estabrook R. W. Spectrophotometric studies of cytochrome P-450 of liver microsomes after induction with phenobarbital and 3-methylcholanthrene. Microsomes and Drug Oxidations, J. R. Gillette, A. H. Conney, G. J. Cosmides, R. W. Estabrook, J. R. Fouts, G. J. Mannering. Academic Press Inc, New York 1969; 331–347, (1969)
   Google Scholar
• Hildebrandt A., Remmer H., Estabrook R. W. Cytochrome P-450 in liver microsomes—one pigment or many. Biochem. Biophys. Res. Commun. 1968; 30: 607–612
   PubMed Web of Science ®Google Scholar
• Huang M. T., Wood A. W., Chang R. L., Yagi H., Sayer J. M., Jerina D. M., Conney A. H. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10 tetrahydrobenzo(a)pyrene. Cancer Res. 1986; 46: 558–566
   PubMed Web of Science ®Google Scholar
• Huang C. S., Shen C. Y., Chang K. J., Hsu S. M., Chern H. D. Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br. J. Cancer 1999; 80: 1838–1843
   PubMed Web of Science ®Google Scholar
• Ishibe N., Hankinson S. E., Colditz G. A., Spiegelman D., Willett W. C., Speizer F. E., Kelsey K. T., Hunter D. J. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study. Cancer Res. 1998; 58: 667–671
   PubMed Web of Science ®Google Scholar
• Jefcoate C. R. E., Gaylor J. L., Calabrese R. L. Ligand interactions with cytochrome P-450. I. Binding of primary amines. Biochemistry 1969; 8: 3455–3463
   PubMed Web of Science ®Google Scholar
• Jefcoate C. R. E., Gaylor J. L. Ligand interaction with hemoprotein P-450. II. Influence of phenobarbital and methylcholanthrene induction processes on P-450 spectra. Biochemistry 1969; 8: 3464–3471
   PubMed Web of Science ®Google Scholar
• Kawajiri K., Nakachi K., Imai K., Watanabe J., Hayashi S. The CYP1A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol. 1993; 14: 77–87
   PubMed Web of Science ®Google Scholar
• Kawalek J. C., Levin W., Ryan D., Thomas P. E., Lu A. Y. H. Purification of liver microsomal cytochrome P-448 from 3-methylcholanthrene-treated rabbits. Mol. Pharmacol. 1975; 11: 874–878
   PubMed Web of Science ®Google Scholar
• Kinoshita T., Horie S. Studies on P-450. 3. On the absorption spectrum of P-450 in rabbit liver microsomes. J. Biochem. (Tokyo) 1967; 61: 26–34
   PubMed Web of Science ®Google Scholar
• Kisselev P., Schunck W. H., Roots I., Schwarz D. Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone. Cancer Res. 2005; 65: 2972–2978
   PubMed Web of Science ®Google Scholar
• Kisselev P., Schwarz D., Platt K. L., Schunck W. H., Roots I. Epoxidation of benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 in reconstituted membranes. Effects of charge and nonbilayer phase propensity of the membrane. Eur. J. Biochem. 2002; 269: 1799–1805
   PubMedGoogle Scholar
• Koop D. R., Morgan E. T., Tarr G. E., Coon M. J. Purification and characterization of a unique isozyme of P-450 from liver microsomes of ethanol-treated rabbits. J. Biol. Chem. 1982; 257: 8472–8480
   PubMed Web of Science ®Google Scholar
• Krusekopf S., Roots I. St. John's wort and its constituent hyperforin concordantly regulate expression of genes encoding enzymes involved in basic cellular pathways. Pharmacogenet. Genomics 2005; 15: 817–829
   PubMed Web of Science ®Google Scholar
• Krusekopf S., Roots I., Hildebrandt A. G., Kleeberg U. Time-dependent transcriptional induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by H+/K+-ATPase inhibitors and other xenobiotics. Xenobiotica 2003; 33: 107–118
   PubMed Web of Science ®Google Scholar
• Le Marchand L., Murphy S. P., Hankin J. H., Wilkens L. R., Kolonel L. N. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst. 2000; 92: 154–160
   PubMed Web of Science ®Google Scholar
• Lu A. Y., Kuntzman R., West S., Jacobson M., Conney A. H. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. II. Role of the cytochrome P-450 and P-448 fractions in drug and steroid hydroxylation. J. Biol. Chem. 1972; 247: 1727–1734
   PubMed Web of Science ®Google Scholar
• Mitrunen K., Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat. Res. 2003; 544: 9–41
   PubMed Web of Science ®Google Scholar
• Miyake Y., Gaylor J. L., Mason H. S. Properties of a submicrosomal particle containing P‐450 and flavoprotein. J. Biol. Chem. 1968; 243: 5788–5797
   PubMed Web of Science ®Google Scholar
• Miyoshi Y., Noguchi S. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women. Biomed. Pharmacother. 2003; 57: 471–481
   PubMed Web of Science ®Google Scholar
• Miyoshi Y., Takahashi Y., Egawa C., Noguchi S. Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women. Breast J. 2002; 8: 209–215
   PubMedGoogle Scholar
• Nachmansohn D. Otto Heinrich Warburg. German-Jewish Pioneers in Science 1900–1933, David Nachmansohn. Springer-Verlag Berlin Heidelberg, New York 1979; 233–267
   Google Scholar
• Nebert D. W., Gelboin H. V. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. II. Cellular responses during enzyme induction. J. Biol. Chem. 1968; 243: 6250–6261
   PubMed Web of Science ®Google Scholar
• Nebert D. W. Microsomal cytochromes b5and P450during induction of aryl hydrocarbon hydroxylase activity in mammalian cell culture. J. Biol. Chem. 1970; 245: 515–527
   Web of Science ®Google Scholar
• Nebert D. W., Kon H. Genetic regulation of aryl hydrocarbon hydroxylase induction V. Specific changes in spin state of cytochrome P450from genetically responsive animals. J. Biol. Chem. 1973; 248: 169–178
   PubMed Web of Science ®Google Scholar
• Nelson D. R., Koymans L., Kamataki T., Stegman J. J., Feyereisen F., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W. P450 superfamily; update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6: 1–41
   PubMedGoogle Scholar
• Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Peisach J., Blumberg W.E. Electron paramagnetic resonance study of the high- and low-spin forms of cytochrome P-450 in liver and in liver microsomes from a methylcholanthrene-treated rabbit. Proc. Nat. Acad. Sci. 1970; 67: 172–179
   PubMed Web of Science ®Google Scholar
• Pickett C. B., Remus L., Jeter J., Morin J., Lu A. Y. H. Electroimmunochemical quantification of cytochrome P-450, cytochrome P-448, and epoxide hydrolase in rat liver microsomes. J. Biol. Chem. 1981; 256: 8815–8820
   PubMed Web of Science ®Google Scholar
• Prough R. A. Introduction: Basal and inducible expression of cytochromes P450 and related enzymes. The FASEB Journal 1999; 10: 807–808
   Web of Science ®Google Scholar
• Reichert R., Remmer H. Die Induktion mikrosomaler Cytochrome durch Pharmaka. Naunyn-Schmiedebergs Arch. Exp. Pharmakol. 1964; 247: 374, (Abstract).
   Google Scholar
• Remmer H. Der beschleunigte Abbau von Pharmaka unter dem Einfluss von Luminal. Naunyn-Schmiedebergs Arch. Exp. Pharmakol. 1959; 235: 279–290
   PubMedGoogle Scholar
• Remmer H., Alsleben B. Die Aktivierung der Entgiftung in den Lebermikrosomen während der Gewöhnung. Klin. Wochenschr. 1958; 36: 332–333
   PubMedGoogle Scholar
• Remmer H., Schenkman J., Estabrook R. W., Sasame H., Gillette J., Narasimhulu S., Cooper D. Y., Rosenthal O. Drug interaction with hepatic cytochrome. Mol. Pharmacol. 1965; 2: 187–190
   Web of Science ®Google Scholar
• Saito T., Strobel H. W. Purification to homogeneity and characterization of a form of cytochrome P-450 with high specificity for benzo[α]pyrene from β-naphtoflavone-pretreated rat liver microsomes. J. Biol. Chem. 1981; 256: 984–988
   PubMed Web of Science ®Google Scholar
• Sandhu P., Guo Z., Baba T., Martin M. V., Tukey R. H., Guengerich F. P. Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys. 1994; 309: 168–177
   PubMed Web of Science ®Google Scholar
• Schenkman J. B., Remmer H., Estabrook R. W. Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol. Pharmacol. 1967; 3: 113–123
   PubMed Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Cascorbi I., Schunck W. H., Roots I. Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis 2001; 22: 453–459
   PubMed Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Chernogolov A., Schunck W. H., Roots I. Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns. Biochem. Bioph. Res. Co. 2005b; 336: 779–783
   PubMed Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Ericksen S. S., Szklarz G. D., Chernogolov A., Honeck H., Schunck W. H., Roots I. Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochem Pharmacol. 2004; 15: 1445–1457
   Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Honeck H., Cascorbi I., Schunck W. H., Roots I. Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system. Xenobiotica 2001b; 31: 345–356
   PubMed Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Roots I. St. John's wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1. Cancer Res. 2003; 63: 8062–8068
   PubMed Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Roots I. CYP1A1 genotype-selective inhibition of benzo[a]pyrene activation by quercetin. Eur. J. Cancer 2005; 41: 151–158
   PubMed Web of Science ®Google Scholar
• Schwarz D., Kisselev P., Schunck W.-H., Chernogolov A., Boidol W., Cascorbi I., Roots I. Allelic variants of human cytochrome P4501A1 (CYP1A1): effect of T4621N and 1462V substitutions on steroid hydroxylases specificity. Pharmacogenetics 2000; 10: 519–530
   PubMedGoogle Scholar
• Schwarz D., Roots I. In vitroassessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1. Biochem. Biophys. Res. Commun. 2003; 303: 902–907
   PubMed Web of Science ®Google Scholar
• Sladek N. E., Mannering G. J. Evidence for a new P-450 hemoprotein in hepatic microsomes from methylcholanthrene treated rats. Biochem. Biophys. Res. Commun. 1966; 8: 668–674
   Web of Science ®Google Scholar
• Spurr N. K., Gough A. C., Stevenson K., Wolf C. R. Msp-1 polymorphism detected with a cDNA probe for the P-450 I family on chromosome 15. Nucleic Acids Res. 1987; 15: 5901
   PubMed Web of Science ®Google Scholar
• Szklarz G. D., Paulsen M. D. Molecular modeling of cytochrome P450 1A1: enzyme-substrate interactions and substrate binding affinities. J. Biomol. Struct. Dyn. 2002; 20: 155–162
   PubMed Web of Science ®Google Scholar
• Tsai R., Yu C. A., Gunsalus I. C., Peisach J., Blumberg W., Orme-Johnson W. H., Beinert H. Spin-state changes in cytochrome P-450cam on binding of specific substrates. Proc. Nat. Acad. Sci. 1970; 66: 1157–1163
   PubMed Web of Science ®Google Scholar
• Wester M. R., Johnson E. F., Marques-Soares C., Dansette P. M., Mansuy D., Stout C. D. Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 A resolution: evidence for multiple substrate binding modes. Biochemistry 2003; 42: 6370–6379
   PubMed Web of Science ®Google Scholar
• Williams P. A., Cosme J., Sridhar V., Johnson E. F., McRee D. E. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol. Cell 2000; 5: 121–131
   PubMed Web of Science ®Google Scholar
• Yang K., Lamprecht S. A., Liu Y., Shinozaki H., Fan K., Leung D., Newmark H., Steele V. E., Kelloff G. J., Lipkin M. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 2000; 21: 1655–1660
   PubMed Web of Science ®Google Scholar